2010
DOI: 10.3109/03639040903188471
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacodynamics of a losartan transdermal system for the treatment of hypertension

Abstract: It can be concluded that the developed transdermal matrix patch holds promise for the management of hypertension that needs to be validated by clinical trials.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 8 publications
0
4
0
Order By: Relevance
“…The optimized formulation were evaluated for clarity, pH measurement, drug content, gelation temperature, spreadability, CPR at 6 h, CPR at 2 h, and t 50% . [30]…”
Section: Methodsmentioning
confidence: 99%
“…The optimized formulation were evaluated for clarity, pH measurement, drug content, gelation temperature, spreadability, CPR at 6 h, CPR at 2 h, and t 50% . [30]…”
Section: Methodsmentioning
confidence: 99%
“…The uniform weight formula showed that the formulation of the patch had the same material composition or did not differ much. This indicated the uniformity of the active substance content in the formula [18].…”
Section: Weight Uniformitymentioning
confidence: 75%
“…The optimized formulations were evaluated for clarity, pH measurement, drug content, gelation temperature. 48 …”
Section: Stability Studymentioning
confidence: 97%